Blood cancer treatment in India
Blood cancers affect the blood, bone marrow and lymphatic system. The three main groups are leukaemia, lymphoma and myeloma. They are treated mainly with medicines rather than surgery, and for many patients a bone marrow transplant offers the strongest chance of a lasting cure.
- Main types
- Leukaemia, lymphoma (Hodgkin and non-Hodgkin), and myeloma
- Main treatments
- Chemotherapy, targeted and immune therapy, radiation, bone marrow transplant
- Rarely surgery
- Unlike solid tumours, these are treated systemically, not cut out
- Transplant
- Often the main hope of cure for eligible patients
- Typical stay
- Long. Months for a full course, and longer again for a transplant
- Cost
- Depends on the type and whether a transplant is needed. Estimate before you travel
The three main groups
Leukaemia
Cancer of the blood-forming cells in the bone marrow. Acute forms develop quickly and need urgent treatment; chronic forms progress slowly and are sometimes monitored before treatment begins. Treated with chemotherapy, targeted drugs and often a transplant.
Lymphoma
Cancer of the lymphatic system, divided into Hodgkin and non-Hodgkin types. Hodgkin lymphoma in particular has high cure rates with modern treatment. Chemotherapy and immunotherapy are the mainstays, sometimes with radiation.
Myeloma
Cancer of the plasma cells in the marrow, affecting bones and kidneys. Treated with targeted drug combinations, often followed by an autologous stem cell transplant using your own cells.
Why the exact diagnosis matters so much
Blood cancers are grouped into many precise subtypes, and treatment differs sharply between them. Your bone marrow biopsy and cytogenetic or molecular results are the documents that determine the plan, so send them if you have them.
How they are treated
Because blood cancers circulate rather than sit as a lump, they are treated with medicines that reach the whole body rather than with surgery. Chemotherapy remains central, increasingly alongside targeted drugs that act on specific features of the cancer cells and immunotherapies that recruit your immune system. Radiation is used in some lymphomas and to treat specific sites.
For many patients with leukaemia, myeloma and some lymphomas, a bone marrow transplant is the treatment that offers the best chance of long-term cure. It replaces the diseased marrow with healthy blood-forming stem cells, either your own or a matched donor's. India has established transplant units performing both types for international patients.
How long it takes
Blood cancer treatment asks for a longer commitment than most. A course of chemotherapy runs over months in cycles. A transplant adds weeks as an inpatient and further weeks of close monitoring nearby while the new immune system strengthens. If you are travelling from abroad, plan realistically and expect that a companion will need to stay with you. Your haematologist will give you a specific timeline once the plan is set.
What it costs in India
The range is wide, because treating a chronic leukaemia with tablets and performing an allogeneic transplant are entirely different undertakings. Newer targeted drugs are the most expensive element. India performs this care at a substantial saving compared with Western countries, which for treatment on this scale is a significant difference. You receive a written estimate after a specialist has reviewed your case, with no fee to us built in.
| Procedure | Indicative cost | Hospital stay |
|---|---|---|
| Bone marrow transplant, autologous | $12,000–15,000 | Extended |
| Bone marrow transplant, full match donor | $20,000 | Extended |
| Bone marrow transplant, half match | $25,000 | Extended |
| Chemotherapy, per cycle | from $800 | Day care |
Questions patients ask
Is blood cancer curable?
Some blood cancers are curable, and outcomes have improved considerably. Hodgkin lymphoma and some leukaemias have high cure rates, particularly in younger patients. Others, such as myeloma, are often controlled for many years rather than cured outright. What is realistic depends on your exact subtype and stage, which a haematologist can tell you honestly after seeing your reports.
Will I need a bone marrow transplant?
Not everyone does. It depends on your type of blood cancer, how it responds to initial treatment, your age and general health, and whether a suitable donor is available. A transplant specialist can assess this from your reports. See our bone marrow transplant page.
Can a family member be my donor?
Often yes. A brother or sister is the most likely match, and testing can establish suitability. Where no family match exists, unrelated donor registries are used. Some transplants use your own cells and need no donor at all. The specialist will advise which route fits your case.
Is treatment possible if my cancer has relapsed?
Yes, relapse does not mean the end of options. Second-line treatments, different drug combinations, transplant and newer immune therapies are all used after a relapse. A specialist reviewing your history can tell you what remains available in your situation.
How long will I need to stay in India?
Longer than for most treatments. A chemotherapy course runs over months; a transplant means weeks in hospital plus several more weeks nearby for monitoring. Plan for an extended stay and for a companion to remain with you. Your specialist will give you a specific timeline.
What reports should I send?
Your blood counts, bone marrow biopsy report, and any cytogenetic or molecular testing results are the most valuable, along with recent scans and a summary of treatment already given. These determine the exact subtype, which drives everything else.